August 1st 2025
More health systems are using AI tools to improve defenses, but ransomware groups are using it for phishing, writing malware, and deepfakes.
PER's Satellite Symposia at MHS
August 1-2, 2025
Register Now!
9th Annual School of Nursing Oncology™
August 9, 2025
Register Now!
Oncology Town Hall™ 2025 ESMO-GI Congress Highlights: The Latest Data on Immune-Based Strategies Across Hepatobiliary Cancers
View More
Community Practice Connections™: Selecting and Sequencing Therapy for Patients with DLBCL in an Era of Expanding Options
View More
8th Annual Live Medical Crossfire®: Hematologic Malignancies
View More
A New Era of Targeted Therapy for Advanced NSCLC: Exploring Future Directions for Bispecific Antibodies and AD...
September 6, 2025
Register Now!
Community Practice Connections™: 14th Asia-Pacific Primary Liver Cancer Expert Meeting
View More
Contextualizing Advances in Relapse Refractory DLBCL: Navigating Biomarkers, Emerging Data, and Adverse Event Management to Transform Patient Care
View More
Burst CME™: Tackling Adverse Events With Targeted Therapies for Diffuse B-Cell Lymphoma
View More
Biomarkers in Diffuse Large B-Cell Lymphoma: Empowering Treatment Decisions to Improve Outcomes
View More
Treating Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Current Options and Emerging Approaches
View More
BURST Expert Illustrations and Commentaries™: Exploring the Mechanistic Rationale for CSF-1R– Directed Treatment in Chronic GVHD
View More
Community Practice Connections™: 23rd Annual International Congress on the Future of Breast Cancer West
View More
(CME) Optimizing Management of Ocular Toxicity in Cancer Patients: The Role of Ophthalmologists in the Spectrum of Care
View More
(COPE) Optimizing Management of Ocular Toxicity in Cancer Patients: The Role of Ophthalmologists in the Spectrum of Care
View More
20th Annual New York Lung Cancers Symposium®
November 15, 2025
Register Now!
PER® Liver Cancer Tumor Board: How Do Evolving Data for Immune-Based Strategies in Resectable and Unresectable HCC Impact Multidisciplinary Patient Management Today… and Tomorrow?
View More
Community Practice Connections™: 6th Annual Precision Medicine Symposium – An Illustrated Tumor Board
View More
Advances In™: Taking R/R B-Cell ALL Management to the Next Level With New CAR T Approval
View More
Navigating Low-Grade Serous Ovarian Cancer – Enhancing Diagnosis, Sequencing Therapy, and Contextualizing Novel Advances
View More
Cases & Conversations™: Integrating Novel Approaches to Treatment in First-line ALK+ mNSCLC – Enhancing Patient Outcomes with Real World Multidisciplinary Strategies
View More
Burst CME™: Implementing Appropriate Recognition and Diagnosis of Low-Grade Serous Ovarian Cancer
View More
Burst CME™: Understanding Novel Advances in LGSOC—A Focus on New Mechanisms of Action and Clinical Trials
View More
Burst CME™: Stratifying Therapy Sequencing for LGSOC and Evaluating the Unmet Needs of the Standard of Care
View More
Burst CME™: How is the Newly Approved CAR T-Cell Therapy Impacting R/R B-Cell ALL Management?
View More
Community Practice Connections™: Case Discussions in TNBC… Navigating the Latest Advances and Impact of Disparities in Care
View More
Epithelioid Sarcoma: Applying Clinical Updates to Real Patient Cases
View More
Collaborating Across the Continuum®: Identifying and Treating Epithelioid Sarcoma
View More
Mastering Epithelioid Sarcoma: Enhancing Diagnostic Precision and Tailoring Treatment Strategies
View More
Clinical Showcase™: Selecting the Best Next Steps for a Patient with Epithelioid Sarcoma
View More
Cybersecurity: How the World Measures Up, Country by Country
July 6th 2017The UN has released its annual report on global cybersecurity. The report aims to measure which countries are most committed to making the web more secure, scoring countries according to five pillars: technical, organizational, legal, cooperation and growth potential.
Should Healthcare Systems Be Concerned About Hidden Cobra?
June 21st 2017Another week, another IT security threat with a conveniently catchy name: the U.S. Department of Health and Human Services late last week released a warning about a new threat, or series of threats, that could impact healthcare systems.
ReadyDock's David Engelhardt on Technology to Kill MRSA, C. Diff
March 1st 2017In Part 2 of his interview with HCA News, David Engelhardt, the founder of ReadyDock Inc., discussed the company's chemical-free mobile and tablet disinfection device designed to mitigate the burden of hospital-acquired infections. Here, Engelhardt details how ReadyDock’s technology works and infection-causing bacteria it can kill.
ReadyDock's David Engelhardt Talks Hospital-Acquired Infections
March 1st 2017David Engelhardt, the founder of ReadyDock Inc., met up with HCA News for an interview at the HIMSS17 conference in Orlando, Florida. ReadyDock is chemical-free mobile and tablet disinfection device designed to mitigate the burden of hospital-acquired infections. In this section, Engelhardt speaks of the severity and complexity of the infection issue.
Trivalent Unveils New Data Protection Service for Healthcare Enterprises
February 23rd 2017Trivalent has released a new encryption and file shredding technology, Trivalent Protect, at the HIMSS17 meeting. The new service, which works with the Windows OS, uses AES256 bit encryption and was labeled as the "next-generation" of data protection by the company.
Yiannis Vassiliades on Security Risks that Health IT Must Address
February 23rd 2017At HIMSS17 in Orlando, Florida, Yiannis Vassiliades of Trivalent spoke with HCA News about the cybersecurity risks associated with the healthcare industry, giving a basic example of the potential problems seen in day-to-day life and detailing his background in IT security and his organization’s aims.